Epicardial ganglionated plexus stimulation decreases postoperative inflammatory response in humans

Heart Rhythm

Volumn 9, Issue 6, 2012, Pages 943-950

  Rossi, Pietro ^a   Ricci, Alessandro ^b   De Paulis, Ruggero ^b   Papi, Elsie ^b   Pavaci, Herribert ^a   Porcelli, Daniele ^a   Monari, Giancarlo ^a   Maselli, Daniele ^b   Bellisario, Alessandro ^b   Turani, Franco ^b   Nardella, Saverio ^b   Azzolini, Paolo ^a   Piccirillo, Gianfranco ^c   Quaglione, Raffaele ^c   Valsecchi, Sergio ^d   Bianchi, Stefano ^a  

^a SAN GIOVANNI CALIBITA FATEBENEFRATELLI HOSPITAL   (Italy)

^b EUROPEAN HOSPITAL   (Italy)

^c POLICLINICO UMBERTO I   (Italy)

^d Medtronic Italia   (Italy)

Author keywords

Cardiac surgery; Cytokines; Inflammation; Vagal stimulation

Indexed keywords

EPIDERMAL GROWTH FACTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEASIBILITY STUDY; FEMALE; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HUMAN; INFERIOR VENA CAVA INFERIOR ATRIAL GANGLIONATED PLEXUS STIMULATION; INTENSIVE CARE UNIT; MALE; NERVE STIMULATION; OFF PUMP SURGERY; PHRENIC NERVE PACING; POSTOPERATIVE INFLAMMATION; PRIORITY JOURNAL; REVASCULARIZATION;

AGED; BIOLOGICAL MARKERS; CORONARY ARTERY BYPASS, OFF-PUMP; CORONARY DISEASE; CYTOKINES; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GANGLIA, AUTONOMIC; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PERICARDIUM; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; VAGUS NERVE STIMULATION;

EID: 84861336207     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2012.01.025     Document Type: Article

References (35)

1. J.H. Levy, K.A. Tanaka Inflammatory response to cardiopulmonary bypass Ann Thorac Surg 75 2003 S715 S720
2. S. Wan, A.P. Yim Cytokines in myocardial injury: impact on cardiac surgical approach Eur J Cardiothorac Surg 16 1999 S107 S111
3. K.M. Ho, J.A. Tan Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis Circulation 119 2009 1853 1866
4. S. Wan, J.L. LeClerc, C.H. Huynh Does steroid pretreatment increase endotoxin release during clinical cardiopulmonary bypass? J Thorac Cardiovasc Surg 117 1999 1004 1008
5. A. Franke, W. Lante, V. Fackeldey Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know? Eur J Cardiothorac Surg 28 2005 569 575
6. L.V. Borovikova, S. Ivanova, M. Zhang Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin Nature 405 2000 458 462
7. J. Meregnani, D. Clarençon, M. Vivier Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease Auton Neurosci 160 2011 82 89
8. P. Rossi, S. Bianchi, A. Barretta Post-operative atrial fibrillation management by selective epicardial vagal fat pad stimulation J Interv Card Electrophysiol 24 2009 37 45
9. P. Schauerte, K. Mischke, J. Plisiene Catheter stimulation of cardiac parasympathetic nerves in humans: a novel approach to the cardiac autonomic nervous system Circulation 104 2001 2430 2435
10. P. Rossi, S. Bianchi, G. Monari Vagal tone augmentation to the atrioventricular node in humans: efficacy and safety of burst endocardial stimulation Heart Rhythm 7 2010 683 689
11. S.S. Po, B.J. Scherlag, W.S. Yamanashi Experimental model for paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junctions Heart Rhythm 3 2006 201 208
12. Y. Zhang, I. Ilsar, H.N. Sabbah, T. Ben David, T.N. Mazgalev Relationship between right cervical vagus nerve stimulation and atrial fibrillation inducibility: therapeutic intensities do not increase arrhythmogenesis Heart Rhythm 6 2009 244 250
13. Y. Ishii, R.B. Schuessler, S.L. Gaynor Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation Circulation 111 2005 2881 2888
14. D.H. Pauza, V. Skripka, N. Pauziene, R. Stropus Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart Anat Rec 259 2000 353 382
15. M. Rosas-Ballina, K.J. Tracey Cholinergic control of inflammation J Intern Med 265 2009 663 679
16. X.M. Song, J.G. Li, Y.L. Wang The protective effect of the cholinergic anti-inflammatory pathway against septic shock in rats Shock 30 2008 468 472
17. S. Guarini, D. Altavilla, M.M. Cainazzo Efferent vagal fibre stimulation blunts nuclear factor-kappaB activation and protects against hypovolemic hemorrhagic shock Circulation 107 2003 1189 1194
18. F. The, C. Cailotto, J. van der Vliet Central activation of the cholinergic anti-inflammatory pathway reduces surgical inflammation in experimental post-operative ileus Br J Pharmacol 163 2011 1007 1016
19. A.D. Niederbichler, S. Papst, L. Claassen Burn-induced organ dysfunction: vagus nerve stimulation attenuates organ and serum cytokine levels Burns 35 2009 783 789
20. R.G. Katare, M. Ando, Y. Kakinuma, M. Arikawa, F. Yamasaki, T. Sato Differential regulation of TNF receptors by vagal nerve stimulation protects heart against acute ischemic injury J Mol Cell Cardiol 49 2010 234 244
21. G.M. De Ferrari, H.J. Crijns, M. Borggrefe Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure Eur Heart J 32 2011 847 855
22. Y. Zhang, Z.B. Popovic, S. Bibevski Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model Circ Heart Fail 2 2009 692 699
23. K. Ishida, F. Kimura, M. Imamaki Relation of inflammatory cytokines to atrial fibrillation after off-pump coronary artery bypass grafting Eur J Cardiothorac Surg 29 2006 501 505
24. M. Gaudino, F. Andreotti, R. Zamparelli The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation: is atrial fibrillation an inflammatory complication? Circulation 108 2003 II195 II199
25. Y. Sawa, H. Ichikawa, K. Kagisaki, T. Ohata, H. Matsuda Interleukin-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium J Thorac Cardiovasc Surg 116 1998 511 517
26. H. Yoshikawa, M. Kurokawa, N. Ozaki Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7 Clin Exp Immunol 146 2006 116 123
27. C. Zhang, T.W. Hein, W. Wang, Y. Ren, R.D. Shipley, L. Kuo Activation of JNK and xanthine oxidase by TNF-alpha impairs nitric oxide-mediated dilation of coronary arterioles J Mol Cell Cardiol 40 2006 247 257
28. M.B. Marrero, M. Bencherif Convergence of alpha 7 nicotinic acetylcholine receptor-activated pathways for anti-apoptosis and anti-inflammation: central role for JAK2 activation of STAT3 and NF-kappaB Brain Res 1256 2009 1 7
29. T. Cohen, D. Nahari, L.W. Cerem, G. Neufeld, B.Z. Levi Interleukin-6 induces the expression of vascular endothelial growth factor J Biol Chem 271 1996 736 741
30. S. Yoshida, M. Ono, T. Shono Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis Mol Cell Biol 17 1997 4015 4023
31. Y. Denizot, A. Leguyader, E. Cornu Release of soluble vascular endothelial growth factor receptor-1 (sFlt-1) during coronary artery bypass surgery J Cardiothorac Surg 2 2007 38
32. Z. Yang, B. Zingarelli, C. Szabó Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury Circulation 101 2000 1019 1026
33. M. Mazighi, A. Pellé, W. Gonzalez IL-10 inhibits vascular smooth muscle cell activation in vitro and in vivo Am J Physiol Heart Circ Physiol 287 2004 H866 H871
34. S.M. Zemse, C.W. Chiao, R.H. Hilgers, R.C. Webb Interleukin-10 inhibits the in vivo and in vitro adverse effects of TNF-alpha on the endothelium of murine aorta Am J Physiol Heart Circ Physiol 299 2010 H1160 H1167
35. L. Kornet, A. van Hunnik, K. Michels Stimulation of the intra-cardiac vagal nerves innervating the AV-node to control ventricular rate during AF: specificity, parameter optimization and chronic use up to 3 months J Interv Card Electrophysiol 33 2012 7 18